UPC APP 15/2025

—·EP2401365 +1 more: REENGINEERING MRNA PRIMARY STRUCTURE FOR ENHANCED PROTEIN PRODUCTION

Case details: Status
—
Action
Procedural application
Category
Document Access (RoP262)
Parties: Claimants
Promosome LLC
Reps: Christine Kanz (Hoyng Rokh Monegier); Tobias J. Hessel (Clifford Chance)
Respondents
BioNTech SE
BioNTech Manufacturing GmbH
BioNTech Manufacturing Marburg GmbH
BioNTech Innovative Manufacturing Services GmbH
BioNTech Europe GmbH
Pfizer Manufacturing Belgium NV
Pfizer SAS
Pfizer AB
Pfizer, Inc.
Reps: Georg A. Rauh (Vossius & Partner)
Division: Munich LD
Judges: Andras Kupecz · Judge-rapporteur
Technology: Biotechnology
Language: —
First decided: Mar 10, 2025

Decisions

2025-03-10
Application RoP262A
The Munich Local Division granted Promosome LLC's application under Rule 262A RoP for confidentiality protection of certain exhibits (VB 4a and VB 4b) in its infringement action against BioNTech and Pfizer entities.
Legal issues:Confidentiality Rule 262A RoPTrade secrets
2025-03-10
Application RoP262A
Munich Local Division issued a confidentiality order under Rule 262A RoP in the infringement action by BioNTech/Pfizer entities against Promosome LLC (EP 2 401 365). The order protected specific exhibits (VB 4a and VB 4b) containing confidential licensing information, granting access only to named representatives and specified individuals from each party. The preliminary protection from a prior order was lifted to the extent superseded.
Legal issues:Confidentiality protection under Rule 262A RoPAccess restrictions to confidential exhibitsLifting of preliminary confidentiality order

Documents